BioSig Sells 1M Shares for $1M in Private Placement
Ticker: STEX · Form: 8-K · Filed: Apr 29, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, private-placement, capital-raise
TL;DR
BioSig just raised $1M cash by selling 1M shares privately. Dilution alert!
AI Summary
On April 24, 2025, BioSig Technologies, Inc. reported an unregistered sale of equity securities. The company issued 1,000,000 shares of common stock to an investor in exchange for $1,000,000 in cash. This transaction was conducted under Section 4(a)(2) of the Securities Act of 1933, indicating it was a private placement not involving a public offering.
Why It Matters
This unregistered sale of equity securities provides BioSig Technologies with immediate capital, potentially for operational needs or strategic initiatives, while also diluting existing shareholders.
Risk Assessment
Risk Level: medium — Unregistered sales can indicate a need for capital and may lead to dilution for existing shareholders.
Key Numbers
- 1,000,000 — Shares Sold (Represents unregistered equity securities issued.)
- $1,000,000 — Cash Raised (Proceeds from the private sale of equity.)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- April 24, 2025 (date) — Date of earliest event reported
- 1,000,000 (dollar_amount) — Number of shares sold
- $1,000,000 (dollar_amount) — Cash received
- Section 4(a)(2) (legal_provision) — Exemption from registration
FAQ
What was the specific reason for the unregistered sale of equity securities?
The filing does not explicitly state the specific reason for the unregistered sale, but it was conducted under Section 4(a)(2) of the Securities Act of 1933.
Who was the investor in this private placement?
The filing does not disclose the identity of the investor who purchased the 1,000,000 shares.
What is the price per share in this transaction?
The company sold 1,000,000 shares for $1,000,000, implying a price of $1.00 per share.
Under which exemption from registration was this sale conducted?
The sale was conducted under Section 4(a)(2) of the Securities Act of 1933, which exempts transactions by an issuer not involving any public offering.
When was the transaction dated?
The date of the earliest event reported is April 24, 2025, and the date as of change is April 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding BioSig Technologies, Inc. (STEX).